Covid19 & Project Origins
Covid19 & Project Origins
A shared effort against COVID-19
CoMeCT builds on European efforts initially developed during the COVID-19 crisis. The importance of cross-border cooperation and coordination in the fight against the global COVID-19 pandemic has been highlighted since it began. In particular, it emphasised the need for international clinical research efforts to be connected and synchronised to ensure that results are obtained rapidly while remaining robust, reproducible, and reliable.
This led to the development of different coordination boards, by two separate groups of EU-funded projects.
Adaptive platform clinical trials
The shared work package of RECOVER, EU-RESPONSE, ECRAID-Prime & VACCELERATE which focused initially on coordination and access to European COVID-19 adaptive platform trials. The result of which was the Trial Coordination Board and the Joint Access Advisory Mechanism, which stem from the work developed in these projects on COVID-19 adaptive platform trials.
Learn more about the APT shared work package and the APT Toolbox:
Cohort studies
In February 2022, the meeting titled “Cohorts united against COVID-19”, organised by the European Commission, brought together all the EU-funded COVID-19 cohort projects alongside representatives of other relevant initiatives and bodies. This meeting brought attention to the significant opportunity for constructive collaboration among COVID-19 cohort projects and, as a result of this meeting, the Cohort Coordination Board (CCB) was established.
The CCB was initially managed within ORCHESTRA and later included into VERDI, both projects that focus on cohort studies and the learnings available for future pandemics, with a special focus on some patient groups. In February 2024, as part of the VERDI project, the CCB website was launched to present a common voice for cohort research both to the wider scientific community and to the general public as a whole, and to highlight Europe’s capacity and competence as an attractive base for clinical research.
For information on the initiatives related to cohort studies: